129 related articles for article (PubMed ID: 8141466)
1. Normal activated clotting time despite adequate anticoagulation with ancrod in a patient with heparin-associated thrombocytopenia and thrombosis undergoing cardiopulmonary bypass.
Spiekermann BF; Lake CL; Rich GF; Humphries JE
Anesthesiology; 1994 Mar; 80(3):686-8. PubMed ID: 8141466
[No Abstract] [Full Text] [Related]
2. Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis.
Teasdale SJ; Zulys VJ; Mycyk T; Baird RJ; Glynn MF
Ann Thorac Surg; 1989 Nov; 48(5):712-3. PubMed ID: 2818066
[TBL] [Abstract][Full Text] [Related]
3. Hematologic changes in a patient with heparin-induced thrombocytopenia who underwent cardiopulmonary bypass after ancrod defibrinogenation.
Spiess BD; Gernsheimer T; Vocelka C; Chandler WL; Benak A; Joy JV; Wright I; Hofer BO
J Cardiothorac Vasc Anesth; 1996 Dec; 10(7):918-21. PubMed ID: 8969402
[No Abstract] [Full Text] [Related]
4. Ancrod infusion for anticoagulation during and after PTCA in a patient with heparin-induced thrombocytopenia.
Moore JA; Burket MW; Puri S; Temesy-Armos P; Lachant N; Skeel R
Cathet Cardiovasc Diagn; 1994 Jul; 32(3):286-7. PubMed ID: 7954782
[TBL] [Abstract][Full Text] [Related]
5. Ancrod: the use of snake venom in the treatment of patients with heparin-induced thrombocytopenia and thrombosis undergoing coronary artery bypass grafting: nursing management.
Lathan LO; Staggers SL
Heart Lung; 1996; 25(6):451-60; quiz 461-2. PubMed ID: 8950124
[TBL] [Abstract][Full Text] [Related]
6. Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia.
Demers C; Ginsberg JS; Brill-Edwards P; Panju A; Warkentin TE; Anderson DR; Turner C; Kelton JG
Blood; 1991 Nov; 78(9):2194-7. PubMed ID: 1932741
[TBL] [Abstract][Full Text] [Related]
7. Heparinless cardiopulmonary bypass with ancrod.
O-Yurvati AH; Laub GW; Southgate TJ; McGrath LB
Ann Thorac Surg; 1994 Jun; 57(6):1656-8. PubMed ID: 8010823
[TBL] [Abstract][Full Text] [Related]
8. Cardiopulmonary bypass with danaparoid sodium and ancrod in heparin-induced thrombocytopenia.
Kanagasabay RR; Unsworth-White MJ; Robinson G; Bevan D; Farnsworth G; Haxby EJ; Smith EE
Ann Thorac Surg; 1998 Aug; 66(2):567-9. PubMed ID: 9725413
[TBL] [Abstract][Full Text] [Related]
9. Heparin-associated thrombocytopenia and thrombosis: optimal therapy with ancrod.
Cole CW; Fournier LM; Bormanis J
Can J Surg; 1990 Jun; 33(3):207-10. PubMed ID: 2190683
[TBL] [Abstract][Full Text] [Related]
10. Ancrod: understanding the agent.
Illig KA; Ouriel K
Semin Vasc Surg; 1996 Dec; 9(4):303-14. PubMed ID: 8958607
[No Abstract] [Full Text] [Related]
11. Plasma-modified ACT can be used to monitor bivalirudin (Angiomax) anticoagulation for on-pump cardiopulmonary bypass surgery in a patient with heparin-induced thrombocytopenia.
Jabr K; Johnson JH; McDonald MH; Walsh DL; Martin WD; Johnson AC; Pickett JM; Shantha-Martin U
J Extra Corpor Technol; 2004 Jun; 36(2):174-7. PubMed ID: 15334761
[TBL] [Abstract][Full Text] [Related]
12. Ancrod: a practical alternative to heparin.
Cole CW; Bormanis J
J Vasc Surg; 1988 Jul; 8(1):59-63. PubMed ID: 3385879
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban.
Koster A; Kukucka M; Bach F; Meyer O; Fischer T; Mertzlufft F; Loebe M; Hetzer R; Kuppe H
Anesthesiology; 2001 Feb; 94(2):245-51. PubMed ID: 11176088
[TBL] [Abstract][Full Text] [Related]
14. Heparin-induced thrombosis treated with ancrod.
Brennan MB; MacKean GL
Can J Surg; 1994 Apr; 37(2):161-4. PubMed ID: 8156472
[TBL] [Abstract][Full Text] [Related]
15. Heparin-induced thrombocytopenia and thrombosis: presentation after cardiopulmonary bypass.
Munver R; Schulman IC; Wolf DJ; Rosengart TK
Ann Thorac Surg; 1994 Dec; 58(6):1764-6. PubMed ID: 7979757
[TBL] [Abstract][Full Text] [Related]
16. Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass.
von Segesser LK; Mueller X; Marty B; Horisberger J; Corno A
Perfusion; 2001 Sep; 16(5):411-6. PubMed ID: 11565896
[TBL] [Abstract][Full Text] [Related]
17. Uses of heparin. Ancrod for heparin induced thrombocytopenia.
Soutar RL; Ginsberg JS
BMJ; 1993 May; 306(6889):1410. PubMed ID: 8518620
[No Abstract] [Full Text] [Related]
18. Successful use of Argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient.
Edwards JT; Hamby JK; Worrall NK
Ann Thorac Surg; 2003 May; 75(5):1622-4. PubMed ID: 12735590
[TBL] [Abstract][Full Text] [Related]
19. [Use of ecarin clotting time in whole blood for monitoring recombinant hirudine treatment during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia].
Devignes J; de Maistre E; Grosjean S; Walter AF; Hacquard M; Mulot A; Longrois D; Carteaux JP; Lecompte T
Ann Biol Clin (Paris); 2005; 63(2):201-8. PubMed ID: 15771978
[TBL] [Abstract][Full Text] [Related]
20. Enoxaparin for unstable angina and ancrod for cardiac surgery following heparin allergy.
Smith RE; Townsend GE; Berry BR; Bowen T
Ann Pharmacother; 1996 May; 30(5):476-80. PubMed ID: 8740327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
